1. Home
  2. VTIX vs EQ Comparison

VTIX vs EQ Comparison

Compare VTIX & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VTIX

Virtuix Holdings Inc. Class A Common Stock

N/A

Current Price

$3.66

Market Cap

111.6M

Sector

Technology

ML Signal

N/A

EQ

Equillium Inc.

HOLD

Current Price

$3.05

Market Cap

129.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTIX
EQ
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.6M
129.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
VTIX
EQ
Price
$3.66
$3.05
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
476.9K
922.5K
Earning Date
08-11-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.00
$0.29
52 Week High
$9.00
$3.45

Technical Indicators

Market Signals
Indicator
VTIX
EQ
Relative Strength Index (RSI) 48.44 61.60
Support Level $3.13 $1.54
Resistance Level $4.51 $3.45
Average True Range (ATR) 0.32 0.35
MACD 0.05 -0.01
Stochastic Oscillator 55.71 65.57

Price Performance

Historical Comparison
VTIX
EQ

About VTIX Virtuix Holdings Inc. Class A Common Stock

Virtuix Holdings Inc develops technologies for immersive virtual environments, including both simulated and real-world applications. It develops virtual reality hardware and software, including the Omni Pro, an omni-directional treadmill designed to allow users to walk and run in multiple directions inside video games and other virtual worlds. The company operates at the intersection of gaming, fitness, and enterprise virtual reality. It has commercialized three products. The company operates in a single operating segment: the design, development, marketing, and sale of omni-directional treadmills, accessories, and related services to consumer and commercial customers. It derives revenue through a combination of hardware sales and recurring software and service income.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: